Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility

URLhttps://www.fiercepharma.com/pharma/parkinsons-cel
Source
Date Published10/02/2024

Additional Reshoring Information:

Company/Division name Aspen Neuroscience
Parent companyAspen Neuroscience
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
City reshored to:San Diego
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharma
What domestic positive factors made reshoring more attractive?Automation/technology, Eco-system synergies, Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles